Amylin (8-37), human

Item no.	RP11276-0.5
Manufacturer	GenScript
Amount	0.5 mg
Category	Oncology Neuroscience Metabolism Diabetes Glucose Homeostasis Cholesterol & Lipid Metabolism Regulation of Appetite Molecular Targets for Neuroscience Peptides & Proteins Endocrine Regulation of Lipid Metabolism Peptides By Organ Breast Cancer
Type	Peptides
Specific against	Human (Homo sapiens)
Purity	> 95%
Sequence	ATQRLANFLVHSSNNFGAILSSTNVGSNTY ; {ALA}{THR}{GLN}{ARG}{LEU}{ALA}{ASN}{PHE}{LEU}{VAL}{HIS}{SER}{SER}{ASN}{ASN}{PHE}{GLY}{ALA}{ILE}{LEU}{SER}{SER}{THR}{ASN}{VAL}{GLY}{SER}{ASN}{THR}{TYR}
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	peptide/RP11276-Amylin_8-37_human, Amylin (8-37) selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle. Amylin (8-37) is a truncated peptide of native rat smylin. Amylin (8-37) increases whole-body and muscle insulin sensitivity and consistently reduces basal insulin levels in normal and hGH-induced insulin-resistant rats. Amylin (8-37) also elicits a significant alteration of in-vivo lipid metabolism. </td></tr><tr><th>Solubility</th><td colspan="7"> The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents. </td></tr><tr><th>Purity</th><td colspan="7"> > 95% </td></tr><tr><th>Storage</th><td colspan="7"> Before use, store the peptide in the DRY form at 0C - 5C. For best and most repeatable results, rehydrate the peptide immediately before use. Do not re-freeze any unused portions.</td></tr>
Similar products	Amylin
Available
Country of Origin	USA
Storage Conditions	Before use, store the peptide in the DRY form at 0C - 5C. For best and most repeatable results, rehydrate the peptide immediately before use. Do not re-freeze any unused portions.
Description	Amylin (8-37) selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle. Amylin (8-37) is a truncated peptide of native rat smylin. Amylin (8-37) increases whole-body and muscle insulin sensitivity and consistently reduces basal insulin levels in normal and hGH-induced insulin-resistant rats. Amylin (8-37) also elicits a significant alteration of in-vivo lipid metabolism.
Solubility	The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.5 mg

available

Delivery expected until 9/11/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer